ANNEX PUBLISHERS

Journal of Gastroenterology and its Complications

Editorial Board Member - JGIC

RICHARD K. GILROY

Professor of Medicine
Medical Director of Liver Transplantation
Department of Gastroenterology and Hepatology
University of Kansas Medical Center
United States
BIOGRAPHY:

Dr. Richard K. Gilroy is currently working as a Professor of Medicine and Medical Director of Liver Transplantation at the University of Kansas Medical Center in Kansas City, United States. He received his training at University of Queensland and Princess Alexandra Hospital in Queensland, Australia. He maintains active membership in the American Society of Transplant Surgeons, United Network for Organ Sharing, International Liver Transplant Society (ILTS), and the American Association for the Study of Liver Disease (AASLD). Among his many honors, he holds the position of United Network for Organ Sharing (UNOS) Medical Director of Liver Transplantation and sits on the US Food and Drug Administration Gastrointestinal Drug Advisory Committee. He has served as a section head on the abstract review committee for ILTS, has been a reviewer for the Mayo Clinic Proceedings, and currently serves as a reviewer for Gastrointestinal Endoscopy, American Journal of Transplantation, Liver Transplantation, and Journal of Hepatology. He has authored numerous journal articles, book chapters, and presentations. He has also been a principal investigator or sub-investigator for various studies in the areas of short bowel syndrome, liver transplantation, hepatitis C, and other liver diseases. He currently holds a research grant from the National Institutes of Health Liver Failure Studies Group and is a mentor for an AASLD Nurse Practitioner Training Grant.



RESEARCH INTERESTS:

His principle research focuses on developing and piloting clinical trials of innovative interventions that improve patient’s health outcomes and organ allograft utility. Treatment studies involve Hepatitis C, liver transplantation and short bowel syndrome. In addition, ongoing research endeavors emphasize economic performance and optimizing drug utilization as well as liver donation and allocation policy. The outcomes of experimental subjects in my clinical trials range from improved quality of life to sustained viral response, improved economic practice and utilization review. The goal of these studies is to provide a comprehensive multilevel analysis that might influence clinical and economic performance in a positive manner. My NIH research funding includes a grant from the Liver Failure Studies Group.





Other Editorial Board Members - JGIC

LAURA IRIS COSEN-BINKER

Assistant Professor
Department of Molecular and Cell Biology
Boston University
USA

ANASTASIOS KOULAOUZIDIS

Associate Specialist Gastroenterologist
The Royal Infirmary of Edinburgh
United Kingdom

NIKOLAOS T. PYRSOPOULOS

Associate Professor
Division of Gastroenterology and Hepatology
University of Rutgers
United States

FAZAL KHAWAJA

Chief of Gastroenterology and Hepatology
Director of GI Endoscopy Unit
Dr. Hamid S. Al-Ahmady Hospital
Saudi Arabia

CHI-HIN CHO

Professor
School of Biomedical Sciences
The Chinese University of Hong Kong
Hong Kong
China

AARON P. THRIFT

Assistant Professor
Department of Medicine
University of Baylor College of Medicine
United States

YARON NIV

Clinical Professor of Medicine
Tel-Aviv University
Israel

JOEL E. RICHTER

Professor
Department of Medicine
University of South Florida
United States

Mahesh Goel MS

Associate Professor
Department of Surgical Oncology
Tata Memorial Hospital
India

ALFRED SZE-LOK CHENG

Associate Professor
School of Biomedical Sciences
The Chinese University of Hong Kong (CUHK)
China
Submit Manuscript


Open Access Journals

View All Journals